Screener
United Therapeutics UTHR Other Non-Current Assets
Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by United Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: United Therapeutics’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 6:31 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001082554-26-000027
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Goodwill and other intangible assets, net | 114.1 | 116.5 |
| Property, plant, and equipment, net | 1,930.1 | 1,729.7 |
| Deferred tax assets, net | 311.6 | 357.7 |
| Other non-current assets | 239.5 | 196.9 |
| Total assets | $7,220.1 | $7,880.0 |
| Liabilities and stockholders’ equity | ||
| Current liabilities: | ||
| Accounts payable and accrued expenses | $497.8 | $488.0 |
Item 1. Consolidated Financial Statements
FAQ
- What is United Therapeutics's other non-current assets?
- United Therapeutics (UTHR) reported other non-current assets of $239.5M in Q2 2026.
- How has United Therapeutics's other non-current assets changed year-over-year?
- United Therapeutics's other non-current assets increased by 2.7% year-over-year, from $233.3M to $239.5M.
- What is the long-term trend for United Therapeutics's other non-current assets?
- Over 5 years (2020 to 2025), United Therapeutics's other non-current assets has grown at a 3.0% compound annual growth rate (CAGR), from $169.9M to $196.9M.
- What does other non-current assets mean?
- Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.
Ask your AI about United Therapeutics's other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude